UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM S-8

 

Registration Statement Under the Securities Act of 1933

 

Ekso Bionics Holdings, Inc.

(Exact name of registrant as specified in its charter)

 

Nevada 99-0367049
(State or other jurisdiction of incorporation or
organization)
(I.R.S. Employer Identification No.)
   
1414 Harbour Way, Suite 1201  
Richmond, California 94804
(Address of Principal Executive Offices) (Zip Code)

 

Ekso Bionics 401(k) Plan

Jack Peurach, CEO
Ekso Bionics Holdings, Inc.
1414 Harbour Way, Suite 1201
Richmond, CA 94804
(510) 984-1761

(Name, address and telephone number, including area code, of agent for service)

 

Copy to:

Michael J. O’Donnell, Esq.

Alfredo B. D. Silva, Esq.
Morrison & Foerster, LLP
755 Page Mill Road
Palo Alto, CA 94304
(650) 813-5600

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ¨ Accelerated filer x
Non-accelerated filer ¨ Smaller reporting company x
  Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of Securities Act. ¨

 

Calculation of Registration Fee

 

Title of securities to be
registered(1)
  Amount to be
registered
    Proposed
maximum offering
price per share
    Proposed maximum
aggregate offering
price
    Amount of
registration
fee
 
Common stock, par value $0.001 per share:     392,621(2)   $0.3898(3)   $153,044(3)   $19.87(3)

 

  (1) This Registration Statement covers shares of our common stock, $0.001 par value per share, of Ekso Bionics Holdings, Inc., or the Registrant, that may be issued to the Ekso Bionics 401(k) Plan, or the 401(k) Plan, or its beneficiaries, as employer matching contributions. In addition, pursuant to Rule 416(c) under the Securities Act of 1933, as amended, or the Securities Act, this Registration Statement also covers an indeterminate amount of plan interests in the 401(k) Plan.
  (2) This Registration Statement registers 392,621 shares of common stock for issuance to the 401(k) Plan, or its beneficiaries, as employer matching contributions. In accordance with Rule 416 under the Securities Act, this Registration Statement shall be deemed to cover an indeterminate number of additional shares of common stock, as may be issuable pursuant to future stock dividends, stock splits, or similar transactions.
  (3) Estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(c) and (h) under the Securities Act, based on the average of the high ($0.3996) and low ($0.38) prices of the Registrant’s common stock as reported on the Nasdaq Capital Market, which was $0.3898 on February 6, 2020.

 

 

 

 

 

 

EXPLANATORY NOTE

 

This Registration Statement registers additional securities of the same class as other securities for which registration statements filed on Forms S-8 relating to shares issued to the 401(k) Plan are already effective. Pursuant to General Instruction E of Form S-8 under the Securities Act, we incorporate by reference into this Registration Statement the contents of (a) the registration statement on Form S-8 (File No. 333-230404), filed on January 24, 2018, to the extent related to or incidental to the 401(k) Plan or the securities offered or sold under the 401(k) Plan, and (b) the registration statement on Form S-8 (File No. 333-230404), filed on March 20, 2019 in its entirety, and in each case excluding the Exhibits to such registration statement. This Registration Statement provides for the registration of the offer and sale of an additional 392,621 shares of the Registrant’s common stock to the 401(k) Plan.

 

PART II

 

INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

 

Item 3. Incorporation of Documents by Reference

 

The Registrant incorporates by reference the following documents that the Registrant has previously filed with the Securities and Exchange Commission, or the SEC:

 

(a) The Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2018, filed with the SEC on February 28, 2019;

 

(b) The 401(k) Plan’s Annual Report on Form 11-K for the year ended December 31, 2018, filed with the SEC on March 19, 2019;

 

(c) The portions of our definitive proxy statement on Schedule 14A filed with the SEC on April 30, 2019 that are deemed "filed" under the Exchange Act;

 

(d) The portions of our definitive proxy statement on Schedule 14A filed on February 10, 2020 that are deemed “filed” with the SEC under the Exchange Act;

 

(e) The Registrant’s Quarterly Reports on Form 10-Q for the fiscal quarters ended March 31, 2019, June 30, 2019 and September 30, 2019, filed with the SEC on May 1, 2019, August 1, 2019 and October 30, 2019 respectively;

 

(f) The Registrant’s Current Reports on Form 8-K and Form 8-K/A, as applicable, filed with the SEC on January 18, 2019, January 30, 2019, March 11, 2019, May 6, 2019, May 24, 2019, June 26, 2019, September 20, 2019, October 28, 2019, November 12, 2019, December 20, 2019, December 30, 2019 (Item 8.01), December 30, 2019 (Item 1.01), January 10, 2020 (Item 8.01 only), and January 22, 2020; and

 

(g) The description of the registrant’s common stock contained in the Registrant’s Registration Statement on Form 8-A (File No. 001-37854) filed with the SEC on August 8, 2016, pursuant to Section 12(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), including any amendment or report filed for the purpose of updating such description.

 

All reports and other documents of the Registrant or the 401(k) Plan subsequently filed with the SEC pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act after the date of this Registration Statement and prior to the filing of a post-effective amendment that indicates the Registrant has sold all of the securities offered under this Registration Statement or deregisters the distribution of all such securities then remaining unsold shall be deemed to be incorporated by reference in this Registration Statement and to be a part hereof from the date that the Registrant or the 401(k) Plan, as the case may be, files such report or document; provided, however, that documents or information deemed to have been furnished and not filed in accordance with the rules of the SEC shall not be deemed incorporated by reference into this Registration Statement. Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any subsequently filed document which also is or is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.

 

 

 

 

Item 8. Exhibits

 

Exhibit No.   Description of Exhibit
4.1   Articles of Incorporation of the Registrant (incorporated by reference from Exhibit 3.1 to the Registrant’s Annual Report on Form 10-K filed March 19, 2015)
     
4.2   By-Laws of the Registrant (incorporated by reference from Exhibit 3.4 to the Registrant’s Current Report on Form 8-K filed on January 23, 2014)
     
4.3   Certificate of Designation of Preferences, Rights and Limitations of Series A Convertible Preferred Stock, filed on December 23, 2015 (incorporated by reference from Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed on December 24, 2015)
     
4.4   Certificate of Amendment to Certificate of Designation of Series A Convertible Preferred Stock, filed on April 4, 2016 (incorporated by reference from Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed on April 7, 2016)
     
4.5   Certificate of Change of Ekso Bionics Holdings, Inc. effective May 4, 2016 (incorporated by reference from Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed on May 5, 2016)
     
4.6   Certificate of Amendment of Certificate of Incorporation of the Registrant (incorporated by reference from Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed on December 27, 2017)
     
4.7   Form of specimen certificate (incorporated by reference from Exhibit 4.4 to the Registrant’s Registration Statement on Form S-3 filed on June 23, 2015)
     
4.8   Registration Rights Agreement, dated as of January 15, 2014, by and among the Registrant and the investors named therein (incorporated by reference from Exhibit 10.10 of the Registrant’s Current Report on Form 8-K filed on January 23, 2014)
     
4.9   Registration Rights Agreement, dated as of July 19, 2017, by and among the Registrant and the purchasers named therein (incorporated by reference from Exhibit 10.2 of the Registrant’s Current Report on Form 8-K filed on July 25, 2017)
     
5.1*   Opinion of Snell and Wilmer L.L.P.
     
23.1*   Consent of Snell and Wilmer L.L.P. (included in Exhibit 5.1)
     
23.2*   Consent of OUM & Co., LLP
     
24.1*   Power of Attorney (included in the signature page to this Registration Statement)
     
99.1   The 401(k) Plan (incorporated by reference from Exhibit 99.1 of the Registrant’s Registration Statement on Form S-8 filed on January 24, 2018)

 

In lieu of the opinion of counsel or determination letter contemplated by item 601(b)(5) of Regulation S-K, the Registrant hereby undertakes that it will submit or has submitted the 401(k) Plan and any amendments thereto to the Internal Revenue Service (“IRS”) in a timely manner and has made or will make all changes required by the IRS in order to qualify the 401(k) Plan.

 

*Filed herewith.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Richmond, State of California, on February 12, 2020.

 

  EKSO BIONICS HOLDINGS, INC.
     
  By:  

/s/ John F. Glenn

      John F. Glenn
      Chief Financial Officer
      (principal financial officer)

 

Signatures and POWER OF ATTORNEY

 

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints Jack Peurach and John F. Glenn, or either one of them, his or her true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for such person and in his or her name, place and stead, in any and all capacities, to sign any or all further amendments or supplements (including post-effective amendments filed pursuant to Rule 462(b) of the Securities Act of 1933, as amended) to this registration statement and to file the same, with all exhibits thereto, and other documents in connection therewith, with the SEC, granting unto said attorney-in-fact and agent or either one of them full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully as to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that each of said attorneys-in-fact and agents, or any of them, or his substitutes, may lawfully do or cause to be done by virtue hereof.

 

Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

 

Signatures

 

Title

 

Date

         
/s/ Jack Peurach   Director and Chief Executive Officer   February 12, 2020
Jack Peurach   (principal executive officer)    
         
/s/ John F. Glenn   Chief Financial Officer (principal financial and   February 12, 2020
John F. Glenn   accounting officer)    
         
/s/ Steven Sherman   Director and Chairman of the Board   February 12, 2020
Steven Sherman        
         
/s/ Marilyn Hamilton   Director   February 12, 2020
Marilyn Hamilton        
         

/s/ Thomas A. Schreck

  Director   February 12, 2020
Thomas A. Schreck        
         
/s/ Charlies Li   Director   February 12, 2020
Charles Li        
         
/s/ Stanley Stern   Director   February 12, 2020
Stanley Stern        
         
/s/ Theodore Wang   Director   February 12, 2020
Theodore Wang        

 

 

 

Ekso Bionics 401(k) Plan. Pursuant to the requirements of the Securities Act of 1933, the trustees (or other persons who administer the 401(k) Plan) have duly caused this Registration Statement to be signed on their behalf by the undersigned, thereunto duly authorized in the in the City of Richmond, State of California, on February 12, 2020.

 

  EKSO BIONICS 401(k) Plan.
     
  By:  

/s/ John F. Glenn

      John F. Glenn, on behalf of the Ekso Bionics, Inc., Plan Administrator

 

 

Ekso Bionics (NASDAQ:EKSO)
Historical Stock Chart
From Sep 2020 to Oct 2020 Click Here for more Ekso Bionics Charts.
Ekso Bionics (NASDAQ:EKSO)
Historical Stock Chart
From Oct 2019 to Oct 2020 Click Here for more Ekso Bionics Charts.